Biosimilars ‘Policy Salad’ Setting Back Sector, Canadian Study Says
Biosimilar Use Across Canada Remains Low
The Ontario Drug Policy Research Network has released a new study on biosimilar uptake across Canada, where the use of biosimilars is relatively low in comparison to other OECD countries.
